The relationship between sex hormones and extent of coronary artery disease in postmenopausal women

Chinese Medical Journal

Volumn 120, Issue 1, 2007, Pages 71-73

  Tumur, Odgerel ^a   Han, Jiang Li ^a   Yang, Chi Sun ^a   Mao, Jie Ming ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

Coronary artery disease; Postmenopausal women; Sex hormones

Indexed keywords

ANDROSTENEDIONE; C REACTIVE PROTEIN; ESTRADIOL; FOLLITROPIN; GLUCOSE; PROGESTERONE; SEX HORMONE; TESTOSTERONE;

AGE; ANDROSTENEDIONE BLOOD LEVEL; ANGIOCARDIOGRAPHY; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; DYSLIPIDEMIA; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PROGESTERONE BLOOD LEVEL; PROTEIN BLOOD LEVEL; RISK FACTOR; SMOKING; TESTOSTERONE BLOOD LEVEL;

EID: 33846282743     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200701010-00014     Document Type: Article

References (13)

1. Wang Z, Liu GH, Guo JX. Correlation of coronary artery lesion score with serum lipids and female sex hormones in postmenopausal women. Chin J Cardiovasc Med (Chin) 2000; 5: 193-196.
2. Phillips GB, Pinkernell BH, Jing TY. Relationship between serum sex hormones and coronary artery disease in postmenopausal women. Arterioscler Thromb Vasc Biol 1997; 17: 695-701.
3. Tuttle KT, Short RA, Johnson RJ. Sex differences in uric acid and risk factors for coronary artery disease. Am J Cardiol 2001; 87: 1411-1414.
4. Bairey-Merz CN, Johnson BD, Sharaf BL, Bittner V, Berga SL, Braunstein GD, et al. Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study. J Am Coll Cardiol 2003; 41: 413-419.
5. Liu YR. Association of sex hormones with serum lipids in perimenopausal coronary artery disease patients. Anthology Med (Chin) 1999; 18: 540-541.
6. Wranicz JK, Cygankiewicz I, Rosiak M, Kula K, Zareba W The relationship between sex hormones and lipid profile in men with coronary artery disease. Int J Cardiol 2005; 101: 105-110.
7. Chu MC, Rath KM, Hulie J, Taylor HS. Elevated basal FSH in normal cycling women is associated with unfavorable lipid levels and increased cardiovascular risk. Human Reprod 2003; 18: 1570-1573.
8. Sowers MR, Matthews KA, Jannausch M, Randolph JE, McConnel D, Sutton-Tyrrell K. Hemostatic factors and estrogen during the menopausal transition. J Clin Endocrinol. Metab 2005; 90: 5942-5948.
9. Guthrie JR, Clark MS, Dennerstein L, Burger HG, Serum C-reactive protein and plasma homocysteine levels are associated with hormone therapy use and other factors: a population-based study of middle-aged Australian-born women. Climacteric 2005; 8: 263-270.
10. Tok EC, Ertunc D, Evruke C, Dilek S. The androgenic profile of women with non-insulin dependent diabetes mellitus. J Reprod Med 2004; 49: 746-752.
11. Kim HC, Kemmann E, Shelden RM, Saidi P. Response of blood coagulation parameters to elevated endogenous 17 beta-estradiol levels induced by human menopausal gonadotropins. Am J Obstet Gynecol 1981; 140: 807-810.
12. Kaczmarek A, Reczuch K, Majda J, Banasiak W, Ponikowski P. The association of lower testosterone level with coronary artery disease in postmenopausal women. Intl J Cardiol 2003; 87: 53-57.
13. Barrett-Connor E, Goodman-Gruen D. Dehydroepiandrosterone sulfate does not predict cardiovascular death in postmenopausal women. The Rancho Bernardo Study. Circulation 1995; 91: 1757-1760.